RT Journal Article
SR Electronic
T1 Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.13.20100206
DO 10.1101/2020.05.13.20100206
A1 Iwasaki, Sumio
A1 Fujisawa, Shinichi
A1 Nakakubo, Sho
A1 Kamada, Keisuke
A1 Yamashita, Yu
A1 Fukumoto, Tatsuya
A1 Sato, Kaori
A1 Oguri, Satoshi
A1 Taki, Keisuke
A1 Senjo, Hajime
A1 Hayasaka, Kasumi
A1 Konno, Satoshi
A1 Nishida, Mutsumi
A1 Teshima, Takanori
YR 2020
UL http://medrxiv.org/content/early/2020/05/19/2020.05.13.20100206.abstract
AB We prospectively compared the efficacy of PCR detection of SARS-CoV-2 between paired nasopharyngeal and saliva samples in nine COVID-19 patients. SARS-CoV-2 was detected in saliva in 8 of 9 (89%) patients and in all 11 samples taken within 2 weeks after disease onset. Viral load was equivalent at earlier time points but declined in saliva than nasopharyngeal samples. PCR negativity was also concordant in all 27 saliva samples from 24 patients between nasopharyngeal and saliva samples. These results suggest that saliva is a reliable noninvasive alternative to nasopharyngeal swabs and facilitate widespread PCR testing in the face of shortages of swabs and protective equipment without posing a risk to healthcare workers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available.